what happens if you overeat on glp 1 Part 2 of a 3-Part Series; GLP-1 Medications for Weight Loss Overdose risks increase as demand

According to FDA regulatory status, these peptides are not FDA-approved for human use and are intended for research use only

doi: 10.1073/pnas.1215927110 149 NatarajanNPluznickJL

Regarding pregnancy and breastfeeding, GLP-1 receptor agonists should be avoided, with semaglutide discontinued at least 2 months before a planned pregnancy

Clinical trials show that patients who stay on their maintenance dose continue experiencing gradual weight reduction for 52 weeks or longer, with many seeing cumulative weight loss of 1522% of their starting body weight

So what's the bottom line

Telehealth options available throughout Florida for eligible patients